Tabi 50MG Tablet (30’s) is a medication that contains Bicalutamide, a non-steroidal anti-androgen used primarily in the treatment of prostate cancer. Each tablet is formulated to deliver 50 mg of Bicalutamide, which works by blocking the action of androgens (male hormones) at the cellular level, thereby inhibiting the growth of cancer cells that require these hormones for proliferation. Tabi is often prescribed as part of a comprehensive treatment plan, which may include other therapies such as surgery or radiation. The drug is typically well-tolerated, but like any medication, it may have side effects. Understanding the composition and purpose of Tabi 50MG Tablet is crucial for patients and caregivers to ensure effective management of prostate cancer and to optimize treatment outcomes.